IQVIA Releases 2021 Environmental, Social, and Governance (ESG) Report
February 22 2022 - 7:00AM
Business Wire
IQVIA (NYSE:IQV) today published its 2021 Environmental, Social,
and Governance (ESG) Report. The annual report highlights the
significant efforts the company has made in advancing healthcare
globally, increasing the diversity and engagement of its workforce,
and reducing its global environmental footprint.
“We are proud of the many business accomplishments we had this
past year, but it is especially meaningful to see how our
approximately 79,000 employees have embraced our ambitious
Environmental, Social, and Governance (ESG) goals and supported an
expansion of these programs during 2021,” said Ari Bousbib,
Chairman and Chief Executive Officer of IQVIA. “As an organization,
our commitment to these efforts is unwavering, and we will continue
reporting progress with complete transparency.”
Below are selected highlights of the 2021 report:
- Enhanced ESG reporting: This year’s report was prepared
based on three globally recognized reporting standards: 1) The
Global Reporting Initiative (GRI) framework; 2) The
Sustainable Accounting Standards Board (SASB) standards; and
3) The Task Force on Climate Related Financial Disclosures
(TCFD), the leading set of standards for investors seeking
to understand an organization’s climate approach.
- Achievement of environmental & sustainability goals:
The company reduced its total Greenhouse Gas (GHG) emissions
year-over-year across Scope 1, 2, and 3 emissions categories. It
also transitioned to 100% renewable energy supply at its Scotland
laboratory and initiated efforts for other facilities to achieve
the same over time.
- Commitment to a science-based target: The company
committed to setting a science-based target by end of 2023 to
reduce carbon emissions generated by both IQVIA and its
suppliers.
- Greater board diversity: The company recently appointed
two new directors, increasing gender and racial/ethnic diversity of
the board. Currently four of the company’s 11 directors are
women.
- Enhanced workforce diversity disclosures: The company
provided disclosures on the gender, racial/ethnic diversity profile
of its workforce, including publishing its most recent U.S.
Employment Information Report (EEO-1).
- Of the total U.S. employee population, approximately 61% are
women and approximately 35% identify as non-white, of which 11%
identify as Black or African American
- Of the total newly hired employees in the U.S., approximately
63% were women and approximately 38% identified as non-white, of
which 13% identified as Black or African American
- Of the employees comprising the three most senior job
categories in the U.S. per the EEO-1 report, approximately 62% are
women and approximately 35% identify as non-white, of which more
than 9% identify as Black or African American
- Continued strong employee engagement: Employee
engagement levels improved year-over-year, with 85% of employees
reporting a favorable engagement rating, which was four points
better than the prior year and four points above the FORTUNE 500
company benchmark.
- Recognition of IQVIA’s industry leadership: IQVIA was
recognized on FORTUNE’s list of Most Admired Companies for the
fifth year in a row, ranking #1 in the Healthcare: Pharmacy
Services & Other category for the first time. IQVIA was also
given six Human Capital Management Excellence Awards from the
Brandon Hall Group for its global talent development programs.
The full version of the report is available HERE.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions, and clinical research services to
the life sciences industry. IQVIA creates intelligent connections
across all aspects of healthcare through its analytics,
transformative technology, big data resources and extensive domain
expertise. IQVIA Connected Intelligence™ delivers powerful insights
with speed and agility — enabling customers to accelerate the
clinical development and commercialization of innovative medical
treatments that improve healthcare outcomes for patients. With
approximately 79,000 employees, IQVIA conducts operations in more
than 100 countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors, and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220222005321/en/
Nick Childs, IQVIA Investor Relations (Nchilds@us.imshealth.com)
+1.973.316.3828
Tor Constantino, IQVIA Media Relations
(tor.constantino@iqvia.com) +1.484.567.6732
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jul 2023 to Jul 2024